Balanced news tone
News Sentiment
CODX sentiment intelligence
Co-Diagnostics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
44
Balanced news tone
34 relevant articles
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-12.7% over one week, -39.2% over four weeks, trend inactive, and below fair value.
CODX Stock Price, Quote & Chart
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Earnings
76/100 classification
One-week reaction
-12.7%
Price reacting lower
Trend fit
Trend inactive
-39.2% over four weeks
Fair value
-88.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
19
Negative
10
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stocktwits
Direct company coverage
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval
Co-Diagnostics Inc. (CODX) shares plunged 20% to an all-time low following the announcement of a 1-for-30 reverse stock split. This move aims to regain compliance with Nasdaq's minimum bid price rule. The reverse split will become effective on January 2, resulting in approximatel
- Tone
- Negative 12/100
- Event
- Regulatory and legal
- Published
- 30 Dec 2025 16:09
- Source
- Stocktwits
Investing.com
Direct company coverage
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split
Co-Diagnostics Inc. (NASDAQ:CODX) stock plummeted 13.8% after the company announced a 1-for-30 reverse stock split. This move is intended to bring Co-Diagnostics into compliance with Nasdaq's $1.00 minimum bid price requirement. The reverse split will take effect on January 2, 20
- Tone
- Negative 26/100
- Event
- Market update
- Published
- 30 Dec 2025 15:09
- Source
- Investing.com
Stock Titan
Direct company coverage
Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq
Co-Diagnostics (CODX) has announced a 1-for-30 reverse stock split, effective January 2, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will consolidate outstanding shares, adjust equity incentive plans, and round up fractional shares. The
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Dec 2025 14:09
- Source
- Stock Titan
PR Newswire
Direct company coverage
Co-Diagnostics Announces Reverse Stock Split
Co-Diagnostics, Inc. has announced a 1-for-30 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective January 2, 2026, with trading on a split-adjusted basis beginning the same day. Stockholders approved a reverse split ra
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Dec 2025 14:09
- Source
- PR Newswire